Galectin-3 as a risk factor recurrence of atrial fibrillation in patients with metabolic syndrome

17 March 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 1 - Atrial Fibrillation - Treatment Rhythm Control, Antiarrhythmic Drugs EHRA Premium Access EHRA 2019

ESC 365 is supported by

ESC 365 is supported by